Elixa Medicaments Private Limited - Company Profile

It is a pharma private limited company based in Kolhapur, Maharashtra, India, established in 2017.

2017 Kolhapur, Maharashtra, India Active

Last Updated: February 08, 2026

About Elixa Medicaments Private Limited

Elixa Medicaments Private Limited, a active private limited company, was established on 10 October 2017 in Kolhapur, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33309PN2017PTC172931. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹4.50 M and a paid-up capital of ₹1.17 M.

It upholds a compliant status. Its leadership includes Rajiv Vijayraj Deshpande (Director), Rashmi Rajiv Deshpande (Director). Past directors included Shreya Rajiv Deshpande. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Csno814/2/1Awingorchidhomesfl.No.104Eward,Karandemala, Kolhapur, Maharashtra, 416003.

Company Details

CIN/LLPIN
U33309PN2017PTC172931
Registration Number
172931
Incorporation Date
10 October 2017
Authorized Capital
₹4.50 M
Paid-Up Capital
₹1.17 M
ROC Code
Roc Pune
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 4.50 M as on 08-02-2026
Paid Up Capital ₹ 1.17 M as on 08-02-2026
Company Age 8 Year, 4 Months
Last Filing with ROC 31 Mar 2022
Revenue Growth **** 82.05% (FY 2020)
Profit Growth **** 16.16% (FY 2020)
Ebitda **** -304.16% (FY 2020)
Net Worth 7.13% (FY 2020)
Total Assets **** 19.12% (FY 2020)

Comprehensive Company Insights

Explore comprehensive insights into Elixa Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Elixa Medicaments Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rajiv Vijayraj Deshpande	Director	18 Mar 2020	Current
Rashmi Rajiv Deshpande	Director	10 Oct 2017	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	30 Apr 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elixa Medicaments.

Elixa Medicaments Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 82.05% increase. The company also saw a substantial improvement in profitability, with a 16.16% increase in profit. The company's net worth moved up by a moderate rise of 7.13%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

82.05%

*******

Revenue from Operations

*******

82.05%

*******

Total Assets

*******

19.12%

*******

Profit or Loss

*******

16.16%

*******

Net Worth

*******

7.13%

*******

EBITDA

*******

-304.16%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elixa Medicaments?

In 2019, Elixa Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Elixa Medicaments?

Unlock and access historical data on people associated with Elixa Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Elixa Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixa Medicaments's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elixa Medicaments

Recent Activity within the Organization

Annual General Meeting

The activity Elixa Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
30 Sep 2022
Balance Sheet

Progress on Elixa Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune. was documented.
31 Mar 2022
Director Appointment

Rajiv Vijayraj Deshpande was appointed as a Director was appointed as a Director on 18 Mar 2020 & has been associated with this company since 5 years 10 months . was recorded as a recent event.
18 Mar 2020
Director Appointment

Progress on Rashmi Rajiv Deshpande was appointed as a Director was appointed as a Director on 10 Oct 2017 & has been associated with this company since 8 years 4 months . was documented.
10 Oct 2017
Company Incorporation

The activity Elixa Medicaments Private Limited was registered on 10 Oct 2017 with Roc Pune & aged 8 years 4 months as per MCA records. was completed.
10 Oct 2017

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Elixa Medicaments Private Limited?

The CIN of Elixa Medicaments Private Limited is U33309PN2017PTC172931.

Where is Elixa Medicaments Private Limited headquartered?

Elixa Medicaments Private Limited is headquartered at Csno814/2/1Awingorchidhomesfl.No.104Eward,Karandemala, Kolhapur, Maharashtra, 416003.

When was Elixa Medicaments Private Limited incorporated?

Elixa Medicaments Private Limited was incorporated on 10 October 2017.

Who are the current directors of Elixa Medicaments Private Limited?

The current directors of Elixa Medicaments Private Limited are

What is the primary industry of Elixa Medicaments Private Limited?

The primary industry of Elixa Medicaments Private Limited is Manufacturing.

Is Elixa Medicaments Private Limited a listed company?

Elixa Medicaments Private Limited is unlisted.

What is the capital structure of Elixa Medicaments Private Limited?

The authorized capital of Elixa Medicaments Private Limited is ₹4.50 M, and the paid-up capital is ₹1.17 M.

What is the compliance status of Elixa Medicaments Private Limited?

The compliance status of Elixa Medicaments Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available